Africa In The News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.

Press releases published on July 14, 2026

Jul. 14, 2026

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

Jul. 14, 2026

NIOB’s Newest Seigneurie Assays Show Higher-Grade Heavy Rare Earth Mineralization

Indeterminate GlobeNewswire

Jul. 14, 2026

Verano Hosting Grand Opening Celebration of MÜV Bradfordville on Friday, July 17th, Elevating the Company’s Retail Footprint to 86 Florida Dispensaries and 163 Locations Nationwide

Indeterminate GlobeNewswire

Jul. 14, 2026

Fredonia Mining Expands Growth Potential at El Dorado-Monserrat with 70.75 Metres of 1.29 G/T Au Eq at Herradura Hill

Indeterminate GlobeNewswire

Jul. 14, 2026

Azimut Drills High-Grade Lithium Pegmatites at Wabamisk East

Indeterminate GlobeNewswire

Jul. 14, 2026

Azimut fore des pegmatites à haute teneur en lithium sur Wabamisk Est

Indeterminate GlobeNewswire

Jul. 14, 2026

Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties

Indeterminate GlobeNewswire

Jul. 14, 2026

First Atlantic Nickel & Cobalt Added to NASDAQ Sprott Nickel Miners™ Index, Tracked by the Sprott Nickel Miners ETF (NASDAQ: NIKL)

Indeterminate GlobeNewswire

Jul. 14, 2026

Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody

Indeterminate GlobeNewswire

Jul. 14, 2026

Nucleome Therapeutics strengthens global IP portfolio with US patent for core MCC Technology

Indeterminate GlobeNewswire

Jul. 14, 2026

ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board

Indeterminate GlobeNewswire

Jul. 14, 2026

Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain

Indeterminate GlobeNewswire